Halley E. Gilbert - 01 Mar 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Signature
/s/ Halley E. Gilbert
Issuer symbol
NEO
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
4
Filing time
03 Mar 2022, 18:59:44 UTC
Previous filing
08 Feb 2022
Next filing
03 Jun 2022

Quoteable Key Fact

"Halley E. Gilbert filed Form 4 for NEOGENOMICS INC (NEO) on 03 Mar 2022."

Quick Takeaways

  • This page summarizes Halley E. Gilbert's Form 4 filing for NEOGENOMICS INC (NEO).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Filing timestamp: 03 Mar 2022, 18:59.

What Changed

  • Previous filing in this sequence was filed on 08 Feb 2022.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +42,036 +40% $0.000000 147,396 01 Mar 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +102,623 $0.000000 102,623 01 Mar 2022 Common Stock 102,623 $21.41 Direct F4
holding NEO Stock Option (Right to Buy) 63,331 01 Mar 2022 Common Stock 63,331 $42.21 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 1, 2022, Ms. Gilbert was granted 42,036 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
F2 This balance includes 97 shares that were acquired at a price of $19.16 per share pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the month ended January 31, 2022. The shares were acquired in transactions exempt from Section 16b-3.
F3 On August 17, 2021, Ms. Gilbert was granted 63,331 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F4 On March 1, 2022, Ms. Gilbert was granted 102,623 stock options. These options vest ratably over the first four anniversary dates of the grant date.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .